Brown, A J <br/><br/>
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites.  [electronic resource] 

 -  Journal of virology  Nov 2000 
 - 10269-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-538X 
<br/><br/><label>Standard No.: </label>10.1128/jvi.74.22.10269-10273.2000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Substitution<br/>Drug Resistance, Microbial<br/>Genetic Variation<br/>HIV Infections--drug therapy<br/>HIV Reverse Transcriptase--chemistry<br/>HIV-1--drug effects<br/>Humans<br/>Molecular Sequence Data<br/>Mutagenesis, Site-Directed<br/>Phenotype<br/>Phylogeny<br/>Reverse Transcriptase Inhibitors--pharmacology